"Ochsner Lafayette General Medical Center staffs a total of 461 beds, including 334 at its main campus, 93 at its Lafayette General Orthopaedic campus and 24 at the Behavioral Health Unit. It is the largest full-service acute-care medical center in Acadiana. Over the years, Ochsner Lafayette General Medical Center has expanded its services and facilities to meet the community’s growing needs — our facility boasts a Center of Excellence in Breast Imaging, has an Accredited Cancer Center, an accredited Metabolic and Bariatric Surgery program and is an Advanced Certified Primary Stroke Center and a Blue Cross Blue Shield Blue Distinction Center in Maternity Care and in Bariatrics."

During the past decade, Lafayette General Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lafayette General Medical Center" #1 sponsor was "Takeda" with 2 trials, followed by "Cardiovascular Systems Inc" with 1 trials sponsored, "Cardiva Medical, Inc." with 1 trials sponsored, "Celldex Therapeutics" with 1 trials sponsored and "Cordis Corporation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lafayette General Medical Center" #1 collaborator was "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator, "Lafayette General Health" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator, "Prairie Education and Research Cooperative" with 1 trials as a collaborator and "University of Louisiana at Lafayette" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Lafayette General Medical Center" are "Colitis, Ulcerative" (2 trials), "Breast Cancer" (1 trials), "COVID-19" (1 trials), "Cardiovascular Diseases" (1 trials) and "Corona Virus Infection" (1 trials). Many other conditions were trialed in "Lafayette General Medical Center" in a lesser frequency.

Most popular intervention types in "Lafayette General Medical Center" are "Drug" (5 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials), "Balloon" (1 trials), "Bosutinib" (1 trials) and "CDX-011" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lafayette General Medical Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Lafayette General Medical Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Lafayette General Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lafayette General Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Lafayette General Medical Center has several departments that took part in Clinical trials: "Cancer Center of Acadiana" - 11 trials